Loading…

Cytosolic immunization allows the expression of preATF‐saporin chimeric toxin in eukaryotic cells

ABSTRACT In this work, we have devised an intracellular immunization strategy for the expression in high amounts of ATF‐saporin, a targeted chimeric toxin constituted by the ATF receptor binding domain of human urokinase and the plant ribosome‐inactivating protein saporin, which has been shown to be...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2000-02, Vol.14 (2), p.391-398
Main Authors: Serena Fabbrini, M., Carpani, Daniela, Soria, Marco R., Ceriotti, Aldo
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT In this work, we have devised an intracellular immunization strategy for the expression in high amounts of ATF‐saporin, a targeted chimeric toxin constituted by the ATF receptor binding domain of human urokinase and the plant ribosome‐inactivating protein saporin, which has been shown to be highly cytotoxic to target cells. This strategy may allow the production of highly toxic secretory proteins in eukaryotic cells, avoiding cell suicide caused by autointoxication. The procedure consists of equipping host cells with cytosolic neutralizing antibodies directed toward the toxic domain of the heterologous polypeptide. We show that this intracellular immunization is essential for the synthesis of correctly folded, biologically active ATF‐SAP in the high amounts needed to investigate its in vivo anti‐metastatic potential. Such a strategy should be generally useful for the production of toxic molecules of therapeutic value whose folding and maturation require transit through the eukaryotic secretory pathway. Fabbrini, M. S., Carpani, D., Soria, M. R., Ceriotti, A. Cytosolic immunization allows the expression of preATF‐saporin chimeric toxin in eukaryotic cells. FASEB J. 14, 391–398 (2000)
ISSN:0892-6638
1530-6860
DOI:10.1096/fasebj.14.2.391